Assessing Synopsys (SNPS) Valuation After New Arm AGI CPU And NVIDIA AI Collaboration News

Synopsys (SNPS) has drawn fresh attention after expanding its collaboration with Arm on the Arm AGI CPU for next generation AI infrastructure, while also showcasing deep ties with NVIDIA around agentic AI and accelerated design workflows.

See our latest analysis for Synopsys.

Despite the Arm and NVIDIA collaborations, Synopsys has faced a softer patch in the market. The 30-day share price return of 8.8% and year-to-date share price return of 16.3% are both negative, while the 5-year total shareholder return of 58.1% points to a much stronger longer-term record. This suggests that recent news is being weighed against a reset in expectations and risk appetite.

If you want to see how other AI focused names are trading around similar themes, it is a good moment to scan 35 AI infrastructure stocks

With Synopsys shares down 16.3% year to date but trading only slightly below an implied intrinsic value and around 34% below the average analyst target, the question now is whether this reset signals a genuine opportunity or whether the market already reflects future growth.

Most Popular Narrative: 25.3% Undervalued

At a last close of $401.95 versus a narrative fair value of $537.75, the current setup frames Synopsys as trading at a sizeable discount while analyst expectations lean on a multi year transformation story.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Curious what revenue build, margin profile and earnings multiple this narrative leans on to reach that fair value? The model combines double digit revenue compounding, improving profitability and a premium earnings multiple to justify $537.75, all discounted back using an 8.85% rate while assuming share count continues to climb.

Result: Fair Value of $537.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks around weaker Chinese demand and a softer IP segment, combined with integration and cost reduction challenges from the Ansys deal, could easily put pressure on this narrative.

Find out about the key risks to this Synopsys narrative.

Another View: High P/E Puts Pressure On The Story

While the narrative fair value frames Synopsys as 25.3% undervalued, the current P/E of 69.7x tells a different story. It sits well above the US Software industry at 28.5x, the peer average at 39x, and even the 43.3x fair ratio the market could move towards. This would mean less room for error if growth or margins fall short.

For a closer look at how these valuation gaps stack up against fundamentals, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages so far and still unsure which side you land on? Take a closer look at both angles with 2 key rewards and 3 important warning signs

Looking for more investment ideas?

If Synopsys has your attention, do not stop here. Broaden your watchlist now so you are not late when the next opportunity lines up.

• Target resilience by scanning 69 resilient stocks with low risk scores, which aims to keep volatility in check while still giving you meaningful exposure to the market.
• Hunt for mispriced quality using 61 high quality undervalued stocks, built to surface companies with solid fundamentals that may not be fully appreciated yet.
• Build a steadier income stream with 12 dividend fortresses, highlighting companies that pair higher yields with a focus on sustainability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com